Saturday, December 9, 2023
Home Authors Posts by Editor / Curator

Editor / Curator

853 POSTS 0 COMMENTS
Hollywood Stock Review

Dolphin Entertainment (DLPN), Announces Proposed Public Offering.

Editor / Curator -
Psychedelic Stock Review

Psychedelics CURED My Alcoholism

Editor / Curator -
Psychedelic Stock Review

ClearMind’s (CMND) MEAI and Reducing Alcohol Use.

Editor / Curator -
Internet News

Jose Manuel Calderon Joins Hapbee (HAPB).

Editor / Curator -
Biotech News

ABVC BioPharma (ABVC) up 160% on News

Editor / Curator -
Biotech News

Adial Pharmaceuticals (ADIL) Announces Closing of $4 Million Private Placement Priced...

Editor / Curator -
Biotech News

Adial (ADIL). Don’t Give up Drinking. Just Drink Less!

Editor / Curator -
Biotech News

Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC. Shares...

Editor / Curator -
2023 Watch List

Ardelyx (ARDX) $3.40, Receives FDA Approval.

Editor / Curator -
Hollywood Stock Review
Hollywood Stock Review

Adding Dolphin Entertainment (DLPN) to the Watch List

Editor / Curator -
1234...86Page 3 of 86

Latest article

Hundreds of Stocks Have Fallen Below $1. They’re Still Listed on Nasdaq. (WSJ)

Stand Down Editor / Curator -
Investor-protection advocates say many belong to risky small companies that should be on the OTC market. With 557 names...

Selling Under Cash. LQR House (LQR) Addresses Nasdaq Delisting.

All News Editor / Curator -
If You're a Sophisticated Speculator, and we do Mean Sophisticated, Study LQR House (LQR) or 'the Liquor House' Story.

LQR House (LQR). And the Numbers are In!

All News Editor / Curator -
A Situation Which Can't be Ignored! That's not to say run out and buy it, but this current valuation...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.